Smart sensor could help kidney transplant patients tame diabetes
NCT ID NCT04783441
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a continuous glucose monitor (CGM) helps kidney transplant recipients with type 2 diabetes keep their blood sugar in a healthy range. Eighty adults who received a kidney transplant within the past year and use insulin will wear a Dexcom G6 sensor that tracks glucose levels 24/7. The goal is to see if real-time monitoring improves 'time in range' compared to a blinded sensor that only shows data after 10 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dexcom G6 continuous glucose monitor
- What this could lead to
- If it works, this could show that continuous glucose monitoring helps kidney transplant patients keep their blood sugar in a healthy range more consistently.
- What could go wrong
- This is a small, early-stage study with only 80 participants, so results may not apply to everyone. The device itself does not treat diabetes—it only tracks glucose levels.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UC Davis Health
RECRUITINGSacramento, California, 95817, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Kidney clues may predict eye swelling after cataract surgery in diabetes patients
- AI-Powered trial asks: does adding a second drug cut heart failure risk?
- Scientists hunt for hidden fat molecules that sabotage insulin
- Can a pharmacist check-in boost medication adherence in diabetes and kidney disease?
- New oral diabetes drug shows promise in early safety trial
- Could a simple breathing exercise ease pain and anxiety during nerve testing?